205 related articles for article (PubMed ID: 11877705)
21. The contribution of matrix metalloproteinases and their inhibitors to the development, progression, and rupture of abdominal aortic aneurysms.
Atkinson G; Bianco R; Di Gregoli K; Johnson JL
Front Cardiovasc Med; 2023; 10():1248561. PubMed ID: 37799778
[TBL] [Abstract][Full Text] [Related]
22. Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice.
Steinmetz EF; Buckley C; Shames ML; Ennis TL; Vanvickle-Chavez SJ; Mao D; Goeddel LA; Hawkins CJ; Thompson RW
Ann Surg; 2005 Jan; 241(1):92-101. PubMed ID: 15621996
[TBL] [Abstract][Full Text] [Related]
23. Intraluminal thrombus has a selective influence on matrix metalloproteinases and their inhibitors (tissue inhibitors of matrix metalloproteinases) in the wall of abdominal aortic aneurysms.
Khan JA; Abdul Rahman MN; Mazari FA; Shahin Y; Smith G; Madden L; Fagan MJ; Greenman J; McCollum PT; Chetter IC
Ann Vasc Surg; 2012 Apr; 26(3):322-9. PubMed ID: 22305865
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase 8 (neutrophil collagenase) in the pathogenesis of abdominal aortic aneurysm.
Wilson WR; Schwalbe EC; Jones JL; Bell PR; Thompson MM
Br J Surg; 2005 Jul; 92(7):828-33. PubMed ID: 15918165
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory infiltrates and neovessels are relevant sources of MMPs in abdominal aortic aneurysm wall.
Reeps C; Pelisek J; Seidl S; Schuster T; Zimmermann A; Kuehnl A; Eckstein HH
Pathobiology; 2009; 76(5):243-52. PubMed ID: 19816084
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms.
Davis V; Persidskaia R; Baca-Regen L; Itoh Y; Nagase H; Persidsky Y; Ghorpade A; Baxter BT
Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1625-33. PubMed ID: 9763536
[TBL] [Abstract][Full Text] [Related]
27. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.
Thompson RW; Baxter BT
Ann N Y Acad Sci; 1999 Jun; 878():159-78. PubMed ID: 10415728
[TBL] [Abstract][Full Text] [Related]
28. Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture.
Petersen E; Gineitis A; Wågberg F; Angquist KA
Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):457-61. PubMed ID: 11112465
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
Kadoglou NP; Liapis CD
Curr Med Res Opin; 2004 Apr; 20(4):419-32. PubMed ID: 15119978
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.
Wang H; Keiser JA
Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730
[TBL] [Abstract][Full Text] [Related]
31. Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms.
Yamashita A; Noma T; Nakazawa A; Saito S; Fujioka K; Zempo N; Esato K
World J Surg; 2001 Mar; 25(3):259-65. PubMed ID: 11343173
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases regulate human aortic smooth muscle cell migration during in vitro aging.
Vigetti D; Moretto P; Viola M; Genasetti A; Rizzi M; Karousou E; Pallotti F; De Luca G; Passi A
FASEB J; 2006 Jun; 20(8):1118-30. PubMed ID: 16770011
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture.
Wilson WR; Anderton M; Schwalbe EC; Jones JL; Furness PN; Bell PR; Thompson MM
Circulation; 2006 Jan; 113(3):438-45. PubMed ID: 16432074
[TBL] [Abstract][Full Text] [Related]
34. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms.
Carrell TW; Burnand KG; Wells GM; Clements JM; Smith A
Circulation; 2002 Jan; 105(4):477-82. PubMed ID: 11815431
[TBL] [Abstract][Full Text] [Related]
35. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators.
Rajavashisth TB; Xu XP; Jovinge S; Meisel S; Xu XO; Chai NN; Fishbein MC; Kaul S; Cercek B; Sharifi B; Shah PK
Circulation; 1999 Jun; 99(24):3103-9. PubMed ID: 10377072
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinases and abdominal aortic aneurysms: a potential therapeutic target.
Sinha S; Frishman WH
J Clin Pharmacol; 1998 Dec; 38(12):1077-88. PubMed ID: 11301559
[TBL] [Abstract][Full Text] [Related]
37. Systemic dilation diathesis in patients with abdominal aortic aneurysms: a role for matrix metalloproteinase-9?
van Laake LW; Vainas T; Dammers R; Kitslaar PJ; Hoeks AP; Schurink GW
Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):371-7. PubMed ID: 15749037
[TBL] [Abstract][Full Text] [Related]
38. Smooth muscle cells from abdominal aortic aneurysms are unique and can independently and synergistically degrade insoluble elastin.
Airhart N; Brownstein BH; Cobb JP; Schierding W; Arif B; Ennis TL; Thompson RW; Curci JA
J Vasc Surg; 2014 Oct; 60(4):1033-41; discussion 1041-2. PubMed ID: 24080131
[TBL] [Abstract][Full Text] [Related]
39. Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms.
Crowther M; Goodall S; Jones JL; Bell PR; Thompson MM
J Vasc Surg; 2000 Sep; 32(3):575-83. PubMed ID: 10957667
[TBL] [Abstract][Full Text] [Related]
40. Elastogenic inductability of smooth muscle cells from a rat model of late stage abdominal aortic aneurysms.
Gacchina CE; Deb P; Barth JL; Ramamurthi A
Tissue Eng Part A; 2011 Jul; 17(13-14):1699-711. PubMed ID: 21341992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
